OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 127 filers reported holding OCULAR THERAPEUTIX INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $124,461 | -35.5% | 18,196 | -14.2% | 0.02% | -28.0% |
| Q1 2024 | $192,911 | +370.6% | 21,199 | +130.6% | 0.02% | +212.5% |
| Q4 2023 | $40,996 | +540.0% | 9,192 | +350.6% | 0.01% | +300.0% |
| Q3 2023 | $6,406 | +22.2% | 2,040 | +100.8% | 0.00% | 0.0% |
| Q2 2023 | $5,243 | -4.6% | 1,016 | -2.6% | 0.00% | 0.0% |
| Q1 2023 | $5,497 | +150.2% | 1,043 | +33.4% | 0.00% | +100.0% |
| Q4 2022 | $2,197 | -26.8% | 782 | +8.5% | 0.00% | 0.0% |
| Q3 2022 | $3,000 | – | 721 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,618,861 | $79,675,000 | 100.00% |
| Opaleye Management Inc. | 6,480,000 | $91,886,000 | 15.26% |
| DELTEC ASSET MANAGEMENT LLC | 2,167,313 | $30,732,000 | 4.23% |
| Kamunting Street Capital Management, L.P. | 624,201 | $8,851,000 | 3.58% |
| GREAT POINT PARTNERS LLC | 919,887 | $13,044,000 | 2.74% |
| Endurant Capital Management LP | 570,970 | $8,096,000 | 2.22% |
| Rubric Capital Management LP | 2,156,542 | $30,580,000 | 1.92% |
| Affinity Asset Advisors, LLC | 250,000 | $3,545,000 | 1.27% |
| Altium Capital Management LP | 256,152 | $3,632,000 | 0.84% |
| Ikarian Capital, LLC | 700,000 | $9,928,000 | 0.80% |